Previous close | 3.2000 |
Open | 3.2000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 44.00 |
Expiry date | 2024-08-16 |
Day's range | 3.2000 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 380 |
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Upgraded profit guidance by GSK stood out today in a session featuring updates by Next, Smith & Nephew and Sensodyne business Haleon. The quartet all signalled robust trading at the start of 2024, helping the FTSE 100 index to begin May in resilient fashion. Traders are also looking ahead to tonight’s US Federal Reserve decision and whether September is still the most likely month for the first cut.
The latest investor updates on stocks that are trending on Wednesday.